RecruitingNot ApplicableNCT06085781

A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers

HN-BIO: A Study of Head and Neck MRI and Tumor Microenvironment Biomarkers


Sponsor

University Health Network, Toronto

Enrollment

60 participants

Start Date

Jan 29, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to explore biomarker development in patients with newly diagnosed Head and neck squamous cell carcinoma (HNSCC) receiving curative therapy.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether special MRI scans and tumor samples can help doctors better understand and predict how head and neck cancer responds to treatment. Researchers want to see if certain biological markers in tumors match what they can see on advanced imaging scans. **You may be eligible if...** - You are 18 or older - You have been diagnosed with squamous cell carcinoma of the head and neck, confirmed by biopsy - Your tumor or lymph node is larger than 3 cm - You are planned to have surgery or radiation (with or without chemotherapy) to treat your cancer - You are able to lie flat comfortably for about 1 hour for MRI scans - Your kidneys are functioning adequately **You may NOT be eligible if...** - You cannot have an MRI (e.g., pacemaker, certain metal implants) - You have had another solid tumor treated within the last 5 years - You are pregnant - You have a known allergy to gadolinium contrast dye - You have a blood clotting disorder that cannot be corrected Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERfMRI

Functional Magnetic Resonance Imaging

OTHEROral Pimonidazole

200 mg and 300 mg tablets


Locations(1)

Princess Margaret Cancer Center

Toronto, Ontario, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06085781


Related Trials